Literature DB >> 81728

Thyroglobulin of varying molecular sizes with different disappearance rates in plasma following subtotal thyroidectomy.

U Feldt-Rasmussen, P H Petersen, H Nielsen, J Date, C M Madsen.   

Abstract

To investigate the possible presence of thyroglobulin (Tg of different molecular sizes in plasma, blood specimens were drawn from patients during and after surgery for thyroid adenoma. Tg was measured in all serum samples by a radioimmunoassay. Selected samples were fractionated on a sepharose CL-6B column, and the fractions were assayed for Tg antigen. In serum drawn at maximum Tg concentration, molecular weights of Tg antigen ranging from 660,000 (19S) to less than 100,000 were found. 6 h later the Tg antigen of mol. wt. less than 100,000 could not be detected, and after 3 days only 19S Tg was present. Correspondingly the plasma Tg concentration vs. time curve showed a biphasic course from which two half-lives could be estimated. For 19S Tg, ta1/2 had a mean value of 4.3 days, whereas the over-all half-life for the mixture of smaller molecules, tb1/2, had a mean value of 3.7 h. The smaller molecules also showed different antigenic reactivity in the assay indicating an altered structure of the molecules. The assumption that this might be due to lack of sialic acid would explain the faster catabolic rate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81728     DOI: 10.1111/j.1365-2265.1978.tb02201.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors:  N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

4.  [Thyroglobulin content of the blood in cases of hanging].

Authors:  E Müller; C Erfurt; W G Franke
Journal:  Z Rechtsmed       Date:  1990

5.  Serum thyroglobulin levels in hypofunctioning nodules before and after surgery.

Authors:  P de Cremoux; M Izembart; F Dagousset; H M Heshmati; C Boutteville; G Vallée
Journal:  Klin Wochenschr       Date:  1985-10-15

6.  Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter.

Authors:  U Feldt-Rasmussen; P H Petersen; J Date; C M Madsen
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

7.  Serum Thyroglobulin: Preoperative Levels and Factors Affecting Postoperative Optimal Timing following Total Thyroidectomy.

Authors:  Anery Patel; Valerie Shostrom; Kelly Treude; William Lydiatt; Russell Smith; Whitney Goldner
Journal:  Int J Endocrinol       Date:  2019-02-20       Impact factor: 3.257

8.  Thyroid Remnant Estimation by Diagnostic Dose (131)I Scintigraphy or (99m)TcO4(-) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131)I Imaging.

Authors:  Guanghui Liu; Na Li; Xuena Li; Song Chen; Bulin Du; Yaming Li
Journal:  Biomed Res Int       Date:  2016-01-21       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.